CBT for pharmacotherapy non-remitters—a systematic review of a next-step strategy

Journal of Affective Disorders - Tập 129 - Trang 219-228 - 2011
Helga Rodrigues1, Ivan Figueira1, Raquel Gonçalves1,2, Mauro Mendlowicz1,3, Tânia Macedo1,2, Paula Ventura1,2
1Institute of Psychiatry, Universidade Federal do Rio de Janeiro (IPUB-UFRJ), Brazil
2Institute of Psychology, Universidade Federal do Rio de Janeiro (UFRJ), Brazil
3Department of Psychiatry and Mental Health, Universidade Federal Fluminense (MSM-UFF), Brazil

Tài liệu tham khảo

Baetz, 1998, Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy, Can. J. Psychiatry, 43, 73, 10.1177/070674379804300109 Boschen, 2007, Publication trends in individual anxiety disorders: 10980-2015, J. Anx. Disord., 22, 570, 10.1016/j.janxdis.2007.04.004 Butler, 2006, The empirical status of cognitive-behavioral therapy: a review of meta-analyses, Clin. Psychol. Rev., 26, 17, 10.1016/j.cpr.2005.07.003 Crippa, 2009, Does social phobia remain the ‘Ugly Duckling’ of anxiety disorders?, Rev. Bras. Psiquiatr., 31, 297, 10.1590/S1516-44462009000400002 Etten, 1998, Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis, Clin. Psychol. Psychother., 5, 126, 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H Fava, 2009, Increasing psychological well-being and resilience by psychotherapeutic methods, J. Pers., 77, 1904, 10.1111/j.1467-6494.2009.00604.x Fenske, 2009, Obsessive–compulsive disorder: diagnoses and management, Am. Fam. Phys., 80, 239 Foa, 2009, Effective treatments for PTSD, 549 Goodman, 1989, The Yale-Brown Obessive Compulsive Scale. 1: Development, use, and reliability, Arch. Gen. Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 Guy, 1976, Clinical Global Impressions (CGI), 217 Hamilton, 1959, The assessment of anxiety states by rating, Br. J. Med. Psychol., 32, 50, 10.1111/j.2044-8341.1959.tb00467.x Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Heldt, 2003, Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital, Psychother. Psychosom., 72, 43, 10.1159/000067188 Heldt, 2006, Quality of life and treatment outcome in panic disorder: cognitive behavior group therapy effects in patients refractory to medication treatment, Psychother. Psychosom., 75, 183, 10.1159/000091776 Heldt, 2006, One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission, Behav. Res. Ther., 44, 657, 10.1016/j.brat.2005.05.003 Hinton, 2004, CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study, J. Trauma. Stress, 17, 429, 10.1023/B:JOTS.0000048956.03529.fa Hinton, 2005, A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design, J. Trauma. Stress, 18, 617, 10.1002/jts.20070 Hinton, 2009, Mechanisms of efficacy of CBT for cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response, CNS Neurosci. Ther., 15, 255, 10.1111/j.1755-5949.2009.00100.x Hoffart, 1993, Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy, J. Clin. Psychiatry, 54, 481 Hofmann, 1998, Pretreatment attrition in a comparative treatment outcome study on panic disorder, Am. J. Psych., 155, 43, 10.1176/ajp.155.1.43 Hofmann, 2006, Augmentation of exposure therapy with d-cycloserine for social anxiety disorder, Arch. Gen. Psychiatry, 63, 298, 10.1001/archpsyc.63.3.298 Insel, 2009, Translating scientific opportunity into public health impact. A strategic plan for research on mental illness, Arch. Gen. Psychiatry, 66, 128, 10.1001/archgenpsychiatry.2008.540 Kampman, 2002, A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone, J. Clin. Psychiatry, 63, 772, 10.4088/JCP.v63n0904 Koran, 2007, 1 Kushner, 2007, d-cycloserine augmented exposure therapy for obsessive–compulsive disorder, Biol. Psychiatry, 62, 835, 10.1016/j.biopsych.2006.12.020 Mitte, 2005, Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy, Psychol. Bull., 131, 785, 10.1037/0033-2909.131.5.785 Otto, 1999, Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series, Behav. Res. Ther., 37, 763, 10.1016/S0005-7967(98)00176-4 Otto, 2003, Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone, Behav. Res. Ther., 41, 1271, 10.1016/S0005-7967(03)00032-9 Pincus, 1993, Trends in research in two general psychiatric journals in 1969–1990: research on research, Am. J. Psych., 150, 135, 10.1176/ajp.150.1.135 Pollack, 1994, Cognitive behavior therapy for treatment-refractory panic disorder, J. Clin. Psychiatry, 55, 200 Shim, 2008, d-cycloserine augmentation for behavioral therapy, Am. J. Psych., 165, 335, 10.1176/appi.ajp.2008.08030455 Simon, 2008, Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy, J. Clin. Psychiatry, 69, 400, 10.4088/JCP.v69n0309 Simon, 2009, Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial, J. Clin. Psychiatry, 70, 1563, 10.4088/JCP.08m04485blu Simpson, 1999, Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive–compulsive disorder: an open trial, J. Clin. Psychiatry, 60, 584, 10.4088/JCP.v60n0904 Simpson, 2008, A Randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive–compulsive disorder, Am. J. Psychiatry, 165, 621, 10.1176/appi.ajp.2007.07091440 Smits, 2008, A meta-analytic review of the effects of psychotherapy control conditions for anxiety disorders, Psychol. Med., 39, 229, 10.1017/S0033291708003498 Stein, 2009, 7 Tenneij, 2005, Behavior therapy augments response of patients with obsessive–compulsive disorder responding to drug treatment, J. Clin. Psychiatry, 66, 1169, 10.4088/JCP.v66n0913 Tolin, 2004, Cognitive-behavioral therapy for medication nonresponders with obsessive–compulsive disorder: a wait-list-controlled open trial, J. Clin. Psychiatry, 65, 922, 10.4088/JCP.v65n0708 Tolin, 2007, A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive–compulsive disorder patients with prior medication trials, Beh. Ther., 38, 179, 10.1016/j.beth.2006.07.001 Tundo, 2007, Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive–compulsive disorder: a naturalistic study, J. Clin. Psychiatry, 68, 1552, 10.4088/JCP.v68n1013 Tundo, 2009, Efficacia della terapia cognitivo comportamentale nel disturbo ossessivo compulsivo fármaco-resistente. Studio naturalístico a 12 mesi, Giorn. Ital. Psicopat., 15, 243